Andy brings more than 25 years of experience in the medical device industry, with extensive expertise in commercial leadership and launching innovative therapies that solve unmet clinical needs and increase patient access in cardiovascular diseases.
Procyrion Appoints Andrew Davis as Chief Commercial Officer Read More »
CEO Andy Doraiswamy and CFO Damian Rippole will highlight ongoing clinical research, provide updates on commercial momentum, its vascular pipeline
Koya Medical to Present at the Piper Sandler 37th Annual Healthcare Conference Read More »
BERKELEY, Calif. — (November 20, 2025) — Channel Medsystems, Inc., a privately held company dedicated to advancing women’s health with innovative solutions, announced today the appointment of Robert Brown, MBA, CPA, as Chief Financial Officer. Mr. Brown is a seasoned financial executive with deep expertise in strategic finance, operations, and growth planning for healthcare and
Channel Medsystems Appoints Robert Brown, MBA, CPA, as Chief Financial Officer Read More »
Michael Levin-Epstein from Health Innovation Matters, chats with Tara Murphy, Vice President of Marketing at Channel Medsystems, Inc. Together, they discuss Tara’s background and how she came into her role at the company; the commercialization of the company’s flagship product, Cerene, an endometrial cryotherapy device; how market development, brand strategies, and patient engagement have fallen
October is Breast Cancer Awareness Month and for those going through treatment, sometimes the stories of others can be the greatest inspiration.
Diagnosed with cancer at 36 weeks pregnant, mother shares story of survival Read More »
Researchers at UC San Diego School of Medicine have begun a pilot clinical trial to test the efficacy of using ultrasound to stimulate the spleen and reduce COVID-19-related inflammation, decreasing the length of hospital stays.
Using Ultrasound Stimulation to Reduce Inflammation in COVID-19 In-Patients Read More »
Procyrion’s Aortix™ Percutaneous Mechanical Circulatory Support Device to be Showcased at TCT 2021 Annual Meeting
San Francisco, Calif. — (November 6, 2025) — Channel Medsystems, a commercial-stage women’s health company, today announced that more than 5,000 women have now been treated with the Cerene® Cryotherapy Device, underscoring the growing clinical and commercial adoption of the company’s innovative solution for heavy menstrual bleeding (HMB) and dysmenorrhea. Cerene is an FDA-approved endometrial
CEO Andy Doraiswamy will discuss the company’s latest clinical research, strategic growth plans, commercialization progress of its products
Koya Medical to Present at the Stifel 2025 Healthcare Conference in New York Read More »
10/17/25 Ascension Wisconsin is the first in the state to offer a groundbreaking, minimally invasive treatment aimed at providing women suffering from heavy periods with a safe and more convenient path to relief. The procedure uses advanced cryotherapy technology to ablate the uterine lining, significantly reducing heavy menstrual bleeding and cramping. Performed in a physician’s